Estradiol/Levonorgestrel

雌二醇/左炔诺孕酮

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEstradiol/Levonorgestrel
Drug Alias Name左炔诺孕酮/雌二醇Levonorgestrel/EstradiolEstradiol - levonorgestrel mixtEstradiol hemihydrate/levonorgestrelClimara Pro +[7] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionEstrogen receptors agonistsProgesterone receptor agonists
TargetsEstrogen receptorsProgesterone receptor
Therapy Area/IndicationsVasomotor symptomAnorexia NervosaVascular Diseases +[4] 
Global Approved IndicationsVasomotor symptomOsteoporosis, Postmenopausal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2003/11/21
Country/TerritoryUnited States
CombinationsYes EstradiolLevonorgestrel
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentBerlex Laboratories International IncBayer Healthcare Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsVasomotor symptomAnorexia NervosaVascular Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeG03F
Related LinksKEGG